Hello? Walter Olson:
The patenting of software, in contrast to the patenting of chemical and pharmaceutical compounds, generates relatively high litigation costs and low benefits . . .
What’s with the low benefits? It says relatively high litigation costs! What’s not to love?
Oh. You mean low benefits for companies, shareholders, innovators and consumers? Them?
Oh, oh. Never mind.
Originally posted 2013-02-20 14:00:10. Republished by Blog Post Promoter